Wednesday's Movers: Drug Makers Lead S&P 500

Published May 22, 2013

Wednesday's movers: Drug makers lead S&P 500

Filed under: drug rehab treatment methods

The biopharmaceutical company said Tuesday that an asthma drug that it is jointly developing with Sanofi showed promising results in treating moderate-to-severe allergic asthma. MARKETS | Expanded markets coverage • The Tell: Market news and analysis …
Read more on MarketWatch

Biogen Idec seeks approval of fourth MS drug

Filed under: drug rehab treatment methods

Biogen's last two drugs – Tysabri, launched in 2004, and Tecfidera, which was just approved this past March – have both relied on other methods of treating the disease. Lindsey Smith, senior manager of public affairs for the company, told Mass High …
Read more on Boston Business Journal (blog)

Terminating an Addicted Employee

Filed under: drug rehab treatment methods

So long as the employee's illegal drug use is "sufficiently recent to justify the employer's reasonable belief that the drug abuse remain[s] an ongoing problem," the employee is unprotected by the ADA, even if the employee enters treatment. Zenor v. El …
Read more on Human Resource Executive Online